Marlon Silva

1.5k total citations
16 papers, 412 citations indexed

About

Marlon Silva is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marlon Silva has authored 16 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Radiation and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marlon Silva's work include Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Advanced Radiotherapy Techniques (5 papers). Marlon Silva is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Advanced Radiotherapy Techniques (5 papers). Marlon Silva collaborates with scholars based in France, Spain and Switzerland. Marlon Silva's co-authors include S. Supiot, Paul Sargos, Dominique Pasquier, I. Latorzeff, Nicolas Magné, D. Azria, Philippe Bergerot, Pierre Baumann, O. Gilliot and Pierre Richaud and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Marlon Silva

16 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlon Silva France 8 384 113 87 55 46 16 412
Meryem Brihoum France 8 414 1.1× 115 1.0× 49 0.6× 68 1.2× 50 1.1× 12 470
María Ángeles Cabeza Rodríguez Spain 6 290 0.8× 98 0.9× 39 0.4× 40 0.7× 37 0.8× 11 318
Chris Brawley United Kingdom 5 265 0.7× 52 0.5× 71 0.8× 51 0.9× 31 0.7× 11 301
Julie Bowen Canada 9 307 0.8× 119 1.1× 49 0.6× 70 1.3× 24 0.5× 15 383
A. Álvarez Spain 9 326 0.8× 99 0.9× 30 0.3× 28 0.5× 60 1.3× 26 390
Shaun Tolan United Kingdom 10 184 0.5× 53 0.5× 56 0.6× 37 0.7× 30 0.7× 15 283
Andrea Hiltz Canada 3 362 0.9× 68 0.6× 31 0.4× 39 0.7× 42 0.9× 4 407
Raphael Pfeffer Israel 4 622 1.6× 161 1.4× 76 0.9× 74 1.3× 69 1.5× 5 660
Rédouane Bettahar Canada 7 201 0.5× 90 0.8× 23 0.3× 86 1.6× 20 0.4× 16 275
Nirdosh Kumar Gogna Australia 11 297 0.8× 116 1.0× 99 1.1× 24 0.4× 31 0.7× 13 430

Countries citing papers authored by Marlon Silva

Since Specialization
Citations

This map shows the geographic impact of Marlon Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlon Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlon Silva more than expected).

Fields of papers citing papers by Marlon Silva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlon Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlon Silva. The network helps show where Marlon Silva may publish in the future.

Co-authorship network of co-authors of Marlon Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Marlon Silva. A scholar is included among the top collaborators of Marlon Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlon Silva. Marlon Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Roubaud, Guilhem, Marie Kostine, Ray McDermott, et al.. (2025). Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial. European Journal of Cancer. 218. 115293–115293. 2 indexed citations
2.
3.
4.
Sargos, Paul, Lise Roca, Marlon Silva, et al.. (2024). Long-term results of dose escalation (80 vs 70 Gy) combined with long-term androgen deprivation in high-risk prostate cancers: GETUG-AFU 18 randomized trial.. Journal of Clinical Oncology. 42(4_suppl). LBA259–LBA259. 16 indexed citations
5.
Bossi, Alberto, Stéphanie Foulon, Xavier Maldonado, et al.. (2023). Prostate irradiation in men with de novo, low-volume, metastatic, castration-sensitive prostate cancer (mCSPC): Results of PEACE-1, a phase 3 randomized trial with a 2x2 design.. Journal of Clinical Oncology. 41(17_suppl). LBA5000–LBA5000. 32 indexed citations
6.
Roubaud, Guilhem, Marie Kostine, Ray McDermott, et al.. (2022). Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial.. Journal of Clinical Oncology. 40(6_suppl). 19–19. 4 indexed citations
7.
Supiot, S., Dominique Pasquier, Nicolas Magné, et al.. (2021). OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer. European Urology. 80(4). 405–414. 53 indexed citations
8.
Fizazi, Karim, Xavier Maldonado, Stéphanie Foulon, et al.. (2021). A phase 3 trial with a 2x2 factorial design of abiraterone acetate plus prednisone and/or local radiotherapy in men with de novo metastatic castration-sensitive prostate cancer (mCSPC): First results of PEACE-1.. Journal of Clinical Oncology. 39(15_suppl). 5000–5000. 31 indexed citations
9.
10.
Supiot, S., Dominique Pasquier, Nicolas Magné, et al.. (2020). Oligopelvis-GETUG P07: A multicenter phase II trial of combined salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses of prostate cancer.. Journal of Clinical Oncology. 38(6_suppl). 93–93. 5 indexed citations
11.
Kissel, Manon, Marlon Silva, Justine Lequesne, et al.. (2019). Impact of suboptimal tandem implantation on local control and complications in intracavitary brachytherapy for cervix cancer. Brachytherapy. 18(6). 753–762. 7 indexed citations
12.
Pasquier, Dominique, Damaris Patricia Rojas, Dario Zerini, et al.. (2019). Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUG. International Journal of Radiation Oncology*Biology*Physics. 105(4). 727–734. 48 indexed citations
13.
Silva, Marlon, et al.. (2019). Oncologic Outcomes of Adjuvant versus Salvage Radiotherapy after Prostatectomy. Urologia Internationalis. 103(4). 408–414. 2 indexed citations
14.
Palpacuer, Clément, Emmanuel Rio, Dominique Pasquier, et al.. (2018). Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07). International Journal of Radiation Oncology*Biology*Physics. 103(5). 1061–1067. 24 indexed citations
15.
Silva, Marlon, et al.. (2017). Características Econômicas de Empresas e uso de Hedge Accounting: um Estudo em Empresas do Setor de Consumo Não-Cíclico Listadas no Novo Mercado da BM&FBovespa. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 5(2). 74–87. 1 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meryem Brihoum Breakdown of academic impact, for papers by María Ángeles Cabeza Rodríguez Breakdown of academic impact, for papers by Chris Brawley Breakdown of academic impact, for papers by Julie Bowen Breakdown of academic impact, for papers by A. Álvarez Breakdown of academic impact, for papers by Shaun Tolan Breakdown of academic impact, for papers by Andrea Hiltz Breakdown of academic impact, for papers by Raphael Pfeffer Breakdown of academic impact, for papers by Rédouane Bettahar Breakdown of academic impact, for papers by Nirdosh Kumar Gogna
Rankless by CCL
2026